Who We Are

Our Mission: to help people understand, access, and benefit from their epigenome. We also research & develop epigenetic analysis methods in the effort to create new methylation-based medical diagnostic tools.


Science First

TruDiagnostic is built by scientists, so all of our decisions are made with real evidence and real research. We only ever use proven processes and are committed to the high standards that allow us to be a trusted source of epigenetic information.

Aim Big

We want to revolutionize the Health and Aging industry. Biological Aging is only the first step. Our R&D team is working to create tools that look at specific methylation to detect changing disease risk. We're already running clinical trials with products that claim to reduce aging, to see if they’re really as effective as they say they are. We’re working with universities to create new methods of epigenetic identification, and with top scientists from around the world to find new ways to re-examine our existing data.


Epigenetics is a pretty new field. ‘Health’ and ‘Aging’ are used as buzzwords for a lot of pseudoscience, but they’re also real and important concepts in the human effort to lengthen our lifespans and improve long-term quality of life. We want to help educate the public about how habits and choices can change you at the epigenetic level, and how you have more control over your general health than most assume.

Never Settle

‘Close Enough’ is never good enough. We want to deliver the most accurate, most comprehensive epigenetic analysis that we can, without compromise. That’s why we use whole blood instead of the less-studied saliva or urine sample types. Accuracy is more important than ‘It’s easy to collect.’

We Are A Team

The wellbeing of our company depends on the wellbeing of our employees. We support each other, and learn from each other’s diverse experiences. We want to foster a positive, collaborative environment with plenty of opportunity to grow.


Dr. Daniel L. Stickler is the Co-Founder and Chief Medical Officer at Apeiron ZOH Inc. He is also the Medical Director for the Neurohacker Collective

Dr. Stickler, MD

Scientific Advisory Board

Dr. David Haase serves as medical advisor to Evoke Neuroscience – a company that delivers technologies that promote brain health, and Metabolon – which develops metabolomics diagnostics for precision medicine.

Dr. Haase, MD

Scientific Advisory Board

Dr. Dominique Fradin-Read is board certified in Preventive Medicine. She is also a Fellow of the American Academy of Anti-Aging Medicine. She now holds an appointment as Assistant Clinical Professor at the Loma Linda University School of Medicine.

Dr. Fradin-Read, MD

Scientific Advisory Board

Dr. F. Yturralde, MD. is an Interventional Cardiologist. He is an alumni from UCSD and SDSU and completed medical school and training at Tufts U. School of Medicine in Boston. He is specifically trained in complex coronary and peripheral interventions, TAVR and ASD/PFO closures. He has emphasized preventive/integrative cardiology in the last few years.

Dr. Yturralde, MD

Scientific Advisory Board

Dr. Gregory Hannum developed one of the first Epigenetic Clocks. He received his Ph.D in Bioengineering from the University of California. He is an author of more than 16 publications and 4 patents.

Dr. Hannum, PH.D.


Media Contacts

For press inquiries, speaker requests, or kit requests, please contact
support@trudiagnostic.com, or reach out through our Contact Us form.


Want to begin your career in the world of epigenetics? We’re hiring!